Publicaciones científicas

Infectious complications associated with short-term mechanical circulatory support in urgent heart transplant candidates

01-feb-2022 | Revista: Revista Española de Cardiología

Miguel Solla-Buceta  1 , Francisco González-Vílchez  2 , Luis Almenar-Bonet  3 , José Luis Lambert-Rodríguez  4 , Javier Segovia-Cubero  5 , José González-Costello  6 , Juan F Delgado  7 , Félix Pérez-Villa  8 , María G Crespo-Leiro  9 , Diego Rangel-Sousa  10 , Manuel Martínez-Sellés  11 , Gregorio Rábago-Juan-Aracil  12 , Luis De-la-Fuente-Galán  13 , Teresa Blasco-Peiró  14 , Daniela Hervás-Sotomayor  15 , Iris P Garrido-Bravo  16 , Sonia Mirabet-Pérez  17 , Javier Muñiz  18 , Eduardo Barge-Caballero  19


Introduction and objectives: Short-term mechanical circulatory support is frequently used as a bridge to heart transplant in Spain. The epidemiology and prognostic impact of infectious complications in these patients are unknown.

Methods: Systematic description of the epidemiology of infectious complications and analysis of their prognostic impact in a multicenter, retrospective registry of patients treated with short-term mechanical devices as a bridge to urgent heart transplant from 2010 to 2015 in 16 Spanish hospitals.

Results: We studied 249 patients, of which 87 (34.9%) had a total of 102 infections. The most frequent site was the respiratory tract (n=47; 46.1%). Microbiological confirmation was obtained in 78 (76.5%) episodes, with a total of 100 causative agents, showing a predominance of gram-negative bacteria (n=58, 58%). Compared with patients without infection, those with infectious complications showed higher mortality during the support period (25.3% vs 12.3%, P=.009) and a lower probability of receiving a transplant (73.6% vs 85.2%, P=.025). In-hospital posttransplant mortality was similar in the 2 groups (with infection: 28.3%; without infection: 23.4%; P=.471).

Conclusions: Patients supported with temporary devices as a bridge to heart transplant are exposed to a high risk of infectious complications, which are associated with higher mortality during the organ waiting period.

CITA DEL ARTÍCULO  Rev Esp Cardiol (Engl Ed). 2022 Feb;75(2):141-149. doi: 10.1016/j.rec.2020.11.019. Epub 2021 Feb 27.